Articles related to PEER-TO-PEER

The updated ASCO guidelines for stage IV NSCLC provide new treatment recommendations based on the latest evidence. Explore these changes and their potential impact on patient care.

Explore the potential implications of the formation of Risant Health on community oncology, as discussed by industry experts in a recent episode of Cancer Care Business Breakthroughs. Learn about the potential challenges and opportunities this new entity could bring to the healthcare landscape.

The KEYNOTE-789 study results have sparked a debate on the role of immunotherapy in treating stage IV EGFR-mutated NSCLC. While the study did not show a significant benefit of adding pembrolizumab to chemotherapy, experts agree that the potential role of immunotherapy, particularly in combination with anti-angiogenic therapy, should not be completely dismissed.

Dr. Susan Love, a revered figure in the realm of oncology, has left a legacy of patient advocacy and innovative research, driving physicians to approach patient care and cancer research with empathy, courage, and forward-thinking dynamism.

Discover how optometrists are revolutionizing patient care by integrating aesthetic technologies into their practices, offering a comprehensive approach to ocular health and beauty.

Stay abreast with the latest ACP guidelines on the management of acute left-sided colonic diverticulitis that stress a less-aggressive approach to handling uncomplicated cases, revealing a paradigm shift in diverticulitis management.